[1]
N. Martínez Pérez, “Psoriasis and increased cardiovascular risk: cutaneous inflammation as a systemic marker-the role of IL-17 and endothelial dysfunction”, Int J Res Dermatol, vol. 11, no. 4, pp. 352–358, Jun. 2025.